Lexeo Therapeutics, Inc. (LXEO) Tops Q1 EPS by 49c
Tweet
Share
E-mailGet Alerts LXEO Hot Sheet
Join SI Premium – FREE
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q1 EPS of ($0.25), $0.49 better than the analyst estimate of ($0.74). Revenue for the quarter came in at $0.
For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Advance Auto Parts falls on revenue miss, weak guidance
- BTCS posts $1.5M gross profit in Q2 2026, net loss widens
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
